
Validea's guru fundamental report indicates that LAM RESEARCH CORP (LRCX) receives a 100% rating based on their Patient Investor model, which is based on the investment strategy of Warren Buffett. The analysis highlights LRCX's long-term, predictable profitability, low debt, and reasonable valuation as key factors driving the high score, with the stock passing all tests related to earnings predictability, debt service, return on equity, and free cash flow.
Lam Research Corp (LRCX), a large-cap growth stock within the Semiconductors industry, has achieved a notable 100% rating according to Validea's Patient Investor model, a framework based on Warren Buffett's investment principles. This top-tier score, significantly above the 90% threshold indicating strong interest, highlights LRCX's alignment with criteria emphasizing long-term, predictable profitability, low debt, and reasonable valuation. The company successfully met all nine specific tests within this strategy, encompassing critical financial health indicators such as earnings predictability, debt service, return on equity, return on total capital, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return. This comprehensive positive assessment, supported by a general sentiment score of 0.85 (strongly positive) and a specific ticker sentiment of 0.9 for LRCX, underscores the company's robust fundamental standing as perceived by this particular analytical model.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment